1. Serrano, Inmaculada, Luque, Ana, Ruiz-Cerulla, Alexandra, Guardiola, Jordi, Aran, Josep M. 2023. C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients. In Pharmacological research, 197, 106948. doi:10.1016/j.phrs.2023.106948. https://pubmed.ncbi.nlm.nih.gov/37806602/
2. Ho, Derek K, Riva, Rauna, Kirjavainen, Vesa, Skurnik, Mikael, Meri, Seppo. 2012. Functional recruitment of the human complement inhibitor C4BP to Yersinia pseudotuberculosis outer membrane protein Ail. In Journal of immunology (Baltimore, Md. : 1950), 188, 4450-9. doi:10.4049/jimmunol.1103149. https://pubmed.ncbi.nlm.nih.gov/22467648/
3. Serrano, Inmaculada, Luque, Ana, Mitjavila, Francesca, Torras, Joan, Aran, Josep M. 2022. The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity. In Frontiers in immunology, 13, 883743. doi:10.3389/fimmu.2022.883743. https://pubmed.ncbi.nlm.nih.gov/35547734/
4. Luque, Ana, Serrano, Inmaculada, Ripoll, Elia, Torras, Joan, Aran, Josep M. 2019. Noncanonical immunomodulatory activity of complement regulator C4BP(β-) limits the development of lupus nephritis. In Kidney international, 97, 551-566. doi:10.1016/j.kint.2019.10.016. https://pubmed.ncbi.nlm.nih.gov/31982108/
5. Zou, Juan, Chen, Yaokun, Ji, Zeqi, Chen, Yexi, Li, Zhiyang. 2024. Identification of C4BPA as biomarker associated with immune infiltration and prognosis in breast cancer. In Translational cancer research, 13, 25-45. doi:10.21037/tcr-23-1215. https://pubmed.ncbi.nlm.nih.gov/38410217/
6. Röttgerding, Florian, Kraiczy, Peter. 2020. Immune Evasion Strategies of Relapsing Fever Spirochetes. In Frontiers in immunology, 11, 1560. doi:10.3389/fimmu.2020.01560. https://pubmed.ncbi.nlm.nih.gov/32793216/
智鼠故事 
